ERBB2 and breast cancer: Breast cancer is the leading cause of cancer-related deaths in women.6 Clinically, this heterogeneous disease is categorized into four major molecular subtypes: luminal-A, luminal-B, human epidermal growth factor receptor 2 (HER2) overexpressing and triple-negative/basal-like.